Meda is a leading international specialty pharma company with a broad product portfolio reaching more than 80% of the global pharmaceutical market. Sales at the end of 2015 amounted to SEK 19,6 billion. Meda has its own operations in close to 60 countries and our products are sold in more than 150 countries. At the end of 2015 Meda had around 4,600 employees, 2,690 of which worked in sales and marketing.
Our vision is to become a world-leading specialty pharma company with a focus on sustainable and profitable growth to provide value for our patients, shareholders and other stakeholders. Meda pursues this via acquisitions of companies and product rights, long-term partnerships, and enhanced presence in growth markets teamed with late-phase development.
We are dedicated to providing products that serve society by increasing the well-being and quality of life of individuals. Furthermore, Meda contributes to the community via donations to charitable organizations and sponsorship of research.
As a company, our aim is to attract the best talent and reward our employees for outstanding performance. Ever since the start, Meda has focused on creating a culture of entrepreneurship and drive, and the goal has always been to attract people with a strong desire to make a difference. For Meda, a fast pace is of great importance.
Meda AB is the parent company and its head office is in Solna, Sweden. Meda was listed in 1995 at the Stockholm stock market and since 2006 listed under Large Cap on the Nasdaq Stockholm exchange, Sweden.
For more information, please visit: www.meda.se
- Company Name:Meda
(View Trends)
-
Headquarters: (View Map)Solna, Sweden
-
Pharmaceuticals
-
5,000 - 10,000 employees
- 25387526 Global Rank
- 608 Philippines
-
Direct100.00%
-
Mail0.00%
-
Search0.00%
-
Social0.00%
-
Display0.00%
-
Referrals0.00%
- India 100.0%
- Textiles and Nonwovens
- Fabrics
- Finishing
- 0 SDKs
- 0 Total reviews
- App Url: https://itunes.apple.com/app/meda-ab-1/id577726537
- App Support: http://www.meda.se/
- Genre: Medical
- Bundle ID: es.nuatt.Zyclara
- App Size: 4.85 M
- Version: 1.0.1
- Release Date: November 20th, 2012
- Update Date: November 28th, 2012
Description:
Description
This app has been designed to inform you about actinic keratosis, the new concept in its management using Lmax and all the new information about Zyclara. It is intended as a training tool for doctors.
Features include:
• A clear, step-by-step guide to the disease
• An explanation of the new Lmax concept
• Information about Zyclara
Important Notice
Please note that this app is intended only for doctors and is password protected. If you are not a doctor, you should not download this application.
MEDA will not respond to comments posted on iTunes. Adverse events should be reported to the relevant authorities.